In most epithelial and hematopoietic carcinomas, TGF-β signaling acts as a tumor suppressor during early stages, as observed in our previous allergy and breast cancer model, where we evaluated the TGF-β effect on primary tumors. The gene discussed is TGFB1; the disease is neoplasm.